BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7539431)

  • 1. The differential processing of homodimers of reverse transcriptases from human immunodeficiency viruses type 1 and 2 is a consequence of the distinct specificities of the viral proteases.
    Fan N; Rank KB; Leone JW; Heinrikson RL; Bannow CA; Smith CW; Evans DB; Poppe SM; Tarpley WG; Rothrock DJ
    J Biol Chem; 1995 Jun; 270(22):13573-9. PubMed ID: 7539431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase.
    Fan N; Rank KB; Poppe SM; Tarpley WG; Sharma SK
    Biochemistry; 1996 Feb; 35(6):1911-7. PubMed ID: 8639674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease.
    Tomasselli AG; Sarcich JL; Barrett LJ; Reardon IM; Howe WJ; Evans DB; Sharma SK; Heinrikson RL
    Protein Sci; 1993 Dec; 2(12):2167-76. PubMed ID: 7507754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of heterodimeric human immunodeficiency virus type 1 (HIV-1) reverse transcriptase produced by in vitro processing of p66 with recombinant HIV-1 protease.
    Chattopadhyay D; Evans DB; Deibel MR; Vosters AF; Eckenrode FM; Einspahr HM; Hui JO; Tomasselli AG; Zurcher-Neely HA; Heinrikson RL
    J Biol Chem; 1992 Jul; 267(20):14227-32. PubMed ID: 1378437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamic residue 438 within the protease-sensitive subdomain of HIV-1 reverse transcriptase is critical for heterodimer processing in viral particles.
    Navarro JM; Damier L; Boretto J; Priet S; Canard B; Quérat G; Sire J
    Virology; 2001 Nov; 290(2):300-8. PubMed ID: 11883194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and characterization of the reverse transcriptase enzyme from type 1 human immunodeficiency virus using different baculoviral vector systems.
    Pekrun K; Petry H; Jentsch KD; Moosmayer D; Hunsmann G; Lüke W
    Eur J Biochem; 1995 Dec; 234(3):811-8. PubMed ID: 8575439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution and properties of homologous and chimeric HIV-1.HIV-2 p66.p51 reverse transcriptase.
    Howard KJ; Frank KB; Sim IS; Le Grice SF
    J Biol Chem; 1991 Dec; 266(34):23003-9. PubMed ID: 1720776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a human immunodeficiency virus-1 protease cleavage site within the 66,000 Dalton subunit of reverse transcriptase.
    Graves MC; Meidel MC; Pan YC; Manneberg M; Lahm HW; Grüninger-Leitch F
    Biochem Biophys Res Commun; 1990 Apr; 168(1):30-6. PubMed ID: 1691640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative purification of recombinant HIV-1 and HIV-2 reverse transcriptase: preparation of heterodimeric enzyme devoid of unprocessed gene product.
    Warren TC; Miglietta JJ; Shrutkowski A; Rose JM; Rogers SL; Lubbe K; Shih CK; Caviness GO; Ingraham R; Palladino DE
    Protein Expr Purif; 1992 Dec; 3(6):479-87. PubMed ID: 1283095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.
    Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow C; Reardon IM; Howe WJ; DeCamp DL; Craik CS; Heinrikson RL
    J Biol Chem; 1990 Aug; 265(24):14675-83. PubMed ID: 2201691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of the HIV-1 p66 reverse transcriptase/RNase H by the p9 protease in vitro generates active p15 RNase H.
    Schulze T; Nawrath M; Moelling K
    Arch Virol; 1991; 118(3-4):179-88. PubMed ID: 1712581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 (HIV-1) recombinant reverse transcriptase. Asymmetry in p66 subunits of the p66/p66 homodimer.
    Sharma SK; Fan N; Evans DB
    FEBS Lett; 1994 Apr; 343(2):125-30. PubMed ID: 7513287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of a salt bridge between Asp 488 and Lys 465 in HIV-1 reverse transcriptase alters its proteolytic processing and polymerase activity.
    Goobar-Larsson L; Bäckbro K; Unge T; Bhikhabhai R; Vrang L; Zhang H; Orvell C; Strandberg B; Oberg B
    Virology; 1993 Oct; 196(2):731-8. PubMed ID: 7690504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-clade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers.
    Held DM; Kissel JD; Thacker SJ; Michalowski D; Saran D; Ji J; Hardy RW; Rossi JJ; Burke DH
    J Virol; 2007 May; 81(10):5375-84. PubMed ID: 17329328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feline immunodeficiency virus reverse transcriptase: expression, functional characterization, and reconstitution of the 66- and 51-kilodalton subunits.
    Amacker M; Hottiger M; Hübscher U
    J Virol; 1995 Oct; 69(10):6273-9. PubMed ID: 7545246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic release and crystallization of the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase.
    Hostomska Z; Matthews DA; Davies JF; Nodes BR; Hostomsky Z
    J Biol Chem; 1991 Aug; 266(22):14697-702. PubMed ID: 1713588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation.
    Sluis-Cremer N; Arion D; Abram ME; Parniak MA
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1836-47. PubMed ID: 15183348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning, expression, purification, and crystallisation of HIV-2 reverse transcriptase.
    Bird LE; Chamberlain PP; Stewart-Jones GB; Ren J; Stuart DI; Stammers DK
    Protein Expr Purif; 2003 Jan; 27(1):12-8. PubMed ID: 12509979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The catalytic functions of chimeric reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
    Shaharabany M; Hizi A
    J Biol Chem; 1992 Feb; 267(6):3674-8. PubMed ID: 1371274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit.
    Sevilya Z; Loya S; Adir N; Hizi A
    Nucleic Acids Res; 2003 Mar; 31(5):1481-7. PubMed ID: 12595556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.